Evidence mapPaperPMID 41533231Full record

ArticleInternational journal of clinical pharmacy2026

Patient perspectives on drug recalls in the Netherlands: a qualitative study.

Pieter A Annema, Lenny M W Nahar-van Venrooij, Marcel L Bouvy, Rob J van Marum, Hieronymus J Derijks

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pieter A AnnemaDepartment of Pharmacy and Clinical Pharmacology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands. p.annema@jbz.nl.ORCID http://orcid.org/0000-0002-1660-180X
Lenny M W Nahar-van VenrooijJeroen Bosch Academy Research, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.ORCID http://orcid.org/0000-0003-4541-2140
Marcel L BouvyDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-4596-0684
Rob J van MarumDepartment of Pharmacy and Clinical Pharmacology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.ORCID http://orcid.org/0000-0003-4292-532X
Hieronymus J DerijksDepartment of Pharmacy and Clinical Pharmacology, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.ORCID http://orcid.org/0000-0003-1658-3100

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDrug recalls occur regularly with some resulting in medication switches for patients. Limited research into this topic suggests that drug recalls can lead to anxiety and unrest for patients which in turn can affect confidence in and use of medication. In this context, a better understanding of patient perceptions and communication preferences is essential to adequately handle drug recalls and ensure continued medication adherence and trust.

aimThe aim of this study was to elucidate patients' experiences, perceptions, and preferences regarding drug recalls.

methodThis qualitative study comprised focus group discussions with patients that experienced a drug recall, recruited through pharmacies from distinct locations in the Netherlands. We aimed to conduct at least two focus groups, each comprising a minimum of six participants. Audio recordings were transcribed verbatim and analyzed using a thematic analysis approach.

resultsIt was found that patients had limited knowledge of drug recall procedures, often confused them with shortages, and struggled to interpret associated risks. Communication was frequently perceived as unclear, triggering varied emotional responses and, in some cases, reduced trust in and use of medications. Patients preferred pharmacist-led, personalized communication tailored to recall urgency, and emphasized the importance of shared decision-making, particularly during medication substitutions.

conclusionDrug recalls cause a range of emotions in patients, leading to reduced confidence and use of medication in some patients. Preferences centered on understandable, transparent, and personalized communication led by pharmacists. The findings of this study emphasize the importance of embedding patient engagement and tailored communication within pharmacovigilance systems to maintain trust and support shared decision-making during drug recalls.

Indexed as

Health Knowledge, Attitudes, PracticeMedication AdherencePatient PreferenceAdultAgedCommunicationFemaleFocus GroupsHumansMaleMiddle AgedNetherlandsPharmacistsQualitative ResearchTrustDrug recallPatient perspectivesPatient preferencesPharmacovigilanceProvider-patient communicationQualitative research

Identifiers

PMID41533231
PMCPMC13176037

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.